What is Agxio?
Founded in 2018, Agxio operates as a specialized data science and machine learning enterprise. The company focuses on delivering high-impact analytical solutions tailored for the biotech, life sciences, and agricultural science sectors. By deploying advanced algorithmic models, Agxio enables organizations to derive actionable insights from complex biological and environmental datasets. Their market position is defined by a commitment to precision and innovation, bridging the gap between raw data and commercial application in industries that are critical to global sustainability and health outcomes.
How much funding has Agxio raised?
Agxio has raised a total of $2.7M across 1 funding round:
Other Financing Round
$2.7M
Other Financing Round (2022): $2.7M with participation from Development Bank of Wales
Key Investors in Agxio
Development Bank of Wales
The Development Bank of Wales provides sustainable and effective business finance solutions for companies based in or relocating to Wales, offering equity and loan support to technology ventures.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Agxio?
With this major enterprise-level funding, Agxio is poised to transition into a phase of rapid operational scaling. The strategic roadmap likely involves the enhancement of their proprietary machine learning architecture to better serve the evolving needs of the agricultural and biotech markets. As the firm matures, the focus will shift toward deepening its market penetration and establishing long-term partnerships with key industry stakeholders. This capital deployment serves as a catalyst for sustained growth, enabling the company to refine its product suite and solidify its reputation as a leader in specialized data intelligence.
See full Agxio company page
